Polycistronic expression of antibodies
Details for Australian Patent Application No. 2002364956 (hide)
International Classifications
Event Publications
31 July 2003 Complete Application Filed
Priority application(s): 60/400,687 05.08.02 US; 60/331,481 16.11.01 US
21 August 2003 Application Open to Public Inspection
Published as AU-B-2002364956
11 November 2004 Assignment before Grant
IDEC Pharmaceuticals Corporation The application has been assigned to Biogen Idec Inc. 2003
11 September 2008 Application Accepted
Published as AU-B-2002364956
5 February 2009 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 24 Dec 2008. Address for service in Australia - Davies Collison Cave Level 3 303 Coronation Drive Milton Business Centre QLD 4064
28 May 2009 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 24 Dec 2008
28 May 2009 Standard Patent Sealed
10 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002364957-COATING PROCESS AND COMPOSITION FOR SAME
2002364955-STABLE, NON-HAZARDOUS INDICIA FOR BIOCIDAL IRRADIATION OF A PACKAGE
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser